Martin de Bock1, Matthew Cooper2, Adam Retterath2, Jennifer Nicholas3, Trang Ly4, Timothy Jones4, Elizabeth Davis4. 1. Telethon Kids Institute, University of Western Australia, Perth, Australia Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia martin.debock@health.wa.gov.au. 2. Telethon Kids Institute, University of Western Australia, Perth, Australia. 3. Telethon Kids Institute, University of Western Australia, Perth, Australia Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia. 4. Telethon Kids Institute, University of Western Australia, Perth, Australia Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia.
Abstract
AIMS: This study reports continuous glucose monitoring (CGM) adherence patterns and contributing factors in patients who were part of a 6-month clinical trial usingsensor augmented pump therapy with low glucose insulin suspension. METHODS: CGM data from 38 patients usingsensor augmented pump therapy for 6 months were analyzed. CGM adherence was defined by having a working sensor available and determined by the time it was switched on as a proportion of available time for the 6 month study period with allowance for practical CGM use. Age, gender, HbA1c, duration of diagnosis, capillary blood glucose testing frequency, sensor accuracy, and insulin pump alarm frequency were characterized and examined for an association with CGM adherence. RESULTS:Overall CGM adherence was 75% (range: 35% to 96%), CGM adherence was demonstrated to fall after 9 to 11 weeks before reaching a steady rate. CGM adherence patterns showed substantial variation. Mean adherence differed (P < .01) between age groups 72% (<12 years), 69% (12-18 years), and 88% (≥18 years). Sensor accuracy predicted adherence, where every 1% decline in mean absolute difference in a given week was associated with a 0.5% decline in sensor adherence (P < .01). Gender, HbA1c, duration of diagnosis, capillary blood glucose testing frequency, and insulin pump alarm frequency were not associated with CGM adherence. CONCLUSIONS:CGM adherence and patterns of use are individualized. However, a predictable fall in adherence at 9 to 11 weeks may present an opportunity for timed interventions to increase CGM use. Adolescent age and sensor accuracy predict CGM adherence.
RCT Entities:
AIMS: This study reports continuous glucose monitoring (CGM) adherence patterns and contributing factors in patients who were part of a 6-month clinical trial using sensor augmented pump therapy with low glucose insulin suspension. METHODS:CGM data from 38 patients using sensor augmented pump therapy for 6 months were analyzed. CGM adherence was defined by having a working sensor available and determined by the time it was switched on as a proportion of available time for the 6 month study period with allowance for practical CGM use. Age, gender, HbA1c, duration of diagnosis, capillary blood glucose testing frequency, sensor accuracy, and insulin pump alarm frequency were characterized and examined for an association with CGM adherence. RESULTS: Overall CGM adherence was 75% (range: 35% to 96%), CGM adherence was demonstrated to fall after 9 to 11 weeks before reaching a steady rate. CGM adherence patterns showed substantial variation. Mean adherence differed (P < .01) between age groups 72% (<12 years), 69% (12-18 years), and 88% (≥18 years). Sensor accuracy predicted adherence, where every 1% decline in mean absolute difference in a given week was associated with a 0.5% decline in sensor adherence (P < .01). Gender, HbA1c, duration of diagnosis, capillary blood glucose testing frequency, and insulin pump alarm frequency were not associated with CGM adherence. CONCLUSIONS:CGM adherence and patterns of use are individualized. However, a predictable fall in adherence at 9 to 11 weeks may present an opportunity for timed interventions to increase CGM use. Adolescent age and sensor accuracy predict CGM adherence.
Authors: Satish Garg; Ronald L Brazg; Timothy S Bailey; Bruce A Buckingham; Robert H Slover; David C Klonoff; John Shin; John B Welsh; Francine R Kaufman Journal: Diabetes Technol Ther Date: 2012-02-08 Impact factor: 6.118
Authors: Robert H Slover; John B Welsh; Amy Criego; Stuart A Weinzimer; Steven M Willi; Michael A Wood; William V Tamborlane Journal: Pediatr Diabetes Date: 2011-07-03 Impact factor: 4.866
Authors: Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood Journal: N Engl J Med Date: 2010-06-29 Impact factor: 91.245
Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245
Authors: M Rachmiel; Z Landau; M Boaz; K Mazor Aronovitch; N Loewenthal; M Ben-Ami; Y Levy-Shraga; D Modan-Moses; A Haim; S Abiri; O Pinhas-Hamiel Journal: Acta Diabetol Date: 2014-09-16 Impact factor: 4.280
Authors: Roy W Beck; Bruce Buckingham; Kellee Miller; Howard Wolpert; Dongyuan Xing; Jennifer M Block; H Peter Chase; Irl Hirsch; Craig Kollman; Lori Laffel; Jean M Lawrence; Kerry Milaszewski; Katrina J Ruedy; William V Tamborlane Journal: Diabetes Care Date: 2009-08-12 Impact factor: 19.112
Authors: Daniel A Hochfellner; Amra Simic; Marlene T Taucher; Lea S Sailer; Julia Kopanz; Tina Pöttler; Julia K Mader Journal: Biosensors (Basel) Date: 2022-02-09